MPD: List measures where strain CAST/EiJ is an outlier

List measures where CAST/EiJ is an outlier

Click on pulldowns below to see CAST/EiJ means with summary statistic tooltips.
Within each pulldown, the "up" and "down" triangles indicate when this strain is an outlier.
You can also download all phenotypes for this strain and sort by Z score in Excel.

Sort/ Pick	Data set	Procedure / Protocol	Treatment	Phenotype Measure / Variable (click to view)	Panel	No. of Strains	Sex	Age	Sample Size (Avg)	Year
Ackert1:26	Ackert1	DXA	(none)	total body area, head excluded [cm²] total_area 25026 6mo 12mo 20mo	inbred	32	both		N=7	2008

Albers1:1	Albers1	lipid profile	high-fat diet	total cholesterol (plasma CHOL) [mmol/L] chol 1901 baseline after 6wks on diet Δchange	inbred	15	both	6-8wks	N=8	1999

Albers1:2	Albers1	lipid profile	high-fat diet	HDL cholesterol (plasma HDL) [mmol/L] HDLC 1902 baseline after 6wks on diet Δchange	inbred	15	both	6-8wks	N=8	1999

Albers1:3	Albers1	lipid profile	high-fat diet	non-HDL cholesterol (plasma non-HDL) [mmol/L] nonHDLC 1903 baseline after 6wks on diet Δchange	inbred	15	both	6-8wks	N=8	1999

Albers1:10	Albers1	lipid profile	high-fat diet	total phospholipid (plasma) [mmol/L] PL 1910 baseline after 6wks on diet Δchange	inbred	15	both	6-8wks	N=8	1999

Albers1:11	Albers1	lipid profile	high-fat diet	HDL phospholipid (plasma) [mmol/L] PL_HDL 1911 baseline after 6wks on diet Δchange	inbred	15	both	6-8wks	N=8	1999

Albers1:12	Albers1	lipid profile	high-fat diet	non-HDL phospholipid (plasma) [mmol/L] PL_nonHDL 1912 baseline after 6wks on diet Δchange	inbred	15	both	6-8wks	N=8	1999

Albers1:28	Albers1	lipid profile	high-fat diet	triglycerides (plasma TG) (4h fast) [mmol/L] TG 1928 baseline after 6wks on diet Δchange	inbred	15	both	6-8wks	N=8	1999

Auwerx2:45	Auwerx2	monitoring system	(none)	carbon dioxide production, 24h test, day time average [mL/kg/min] vco2_day 114573 CD HFD	inbred w/CC8	9	both	14wks	N=4	2021

Auwerx2:99	Auwerx2	monitoring system	(none)	horizontal activity (beam breaks) at night, basal activity test, for 48h [n/h] horiz_act_night 114627 CD HFD	inbred w/CC8	9	both	19wks	N=4	2021

Auwerx2:101	Auwerx2	monitoring system	(none)	vertical activity (beam breaks) at night, basal activity test, for 48h [n/h] vert_act_night 114629 CD HFD	inbred w/CC8	9	both	19wks	N=4	2021

Auwerx2:151	Auwerx2	metabolic panel	(none)	plasma lactate dehydrogenase amount (LDH) [U/L] LDH 114679 CD HFD	inbred w/CC8	9	both	21wks	N=4	2021

Brown2:53	Brown2	visual water box	(none)	visual acuity, percent correct performance [%] pct_vis_acuit 22553 grating threshold: 0.17 (low) 0.32 0.64 (high)	inbred	14	both	10-18wks	N=7	2004

CGDpheno1:20	CGDpheno1	complete blood count	(none)	platelet count (PLT; units per volume x 10³) [n/µL] PLT 31820	inbred w/CC8	72	both	11wks	N=7	2009

CGDpheno1:31	CGDpheno1	complete blood count	(none)	RBC corpuscular distribution width (RDW) [%] RDW 31831	inbred w/CC8	72	both	11wks	N=7	2009

CGDpheno1:50	CGDpheno1	metabolic panel	(none)	glucose (plasma GLU, 4h fast) [mg/dL] GLU 31850	inbred w/CC8	72	both	12wks	N=7	2009

CGDpheno3:14	CGDpheno3	complete blood count	(none)	RBC corpuscular distribution width (RDW) [%] RDW 43914	CC diallel w/par	62	both	7wks	N=5	2012

CGDpheno3:15	CGDpheno3	complete blood count	(none)	mean RBC corpuscular volume (MCV) [fL] MCV 43915	CC diallel w/par	62	both	7wks	N=5	2012

CGDpheno3:19	CGDpheno3	complete blood count	(none)	hemoglobin concentration distribution width (HDW) [g/dL] HDW 43919	CC diallel w/par	62	both	7wks	N=5	2012

CGDpheno3:20	CGDpheno3	complete blood count	(none)	measured hemoglobin (HGB) [g/dL] mHGB 43920	CC diallel w/par	62	both	7wks	N=5	2012

CGDpheno3:21	CGDpheno3	complete blood count	(none)	calculated hemoglobin (HGB) [g/dL] cHGB 43921	CC diallel w/par	62	both	7wks	N=5	2012

CGDpheno3:22	CGDpheno3	complete blood count	(none)	hematocrit (HCT) [%] HCT 43922	CC diallel w/par	62	both	7wks	N=5	2012

CGDpheno3:40	CGDpheno3	DXA	(none)	whole body bone mineral density (BMD) [g/cm²] BMD 43940	CC diallel w/par	62	both	16wks	N=5	2012

CGDpheno3:41	CGDpheno3	DXA	(none)	whole body bone mineral content (BMC) [g] BMC 43941	CC diallel w/par	62	both	16wks	N=5	2012

CGDpheno3:42	CGDpheno3	DXA	(none)	whole body bone area, head excluded [cm²] bone_area 43942	CC diallel w/par	62	both	16wks	N=5	2012

Chesler2:6	Chesler2	metabolic panel	(none)	carbon dioxide (blood CO₂) [mmol/L] carbon_dioxide 43406	CC diallel w/par	48	both	7-15wks	N=2	2011

Chesler2:21	Chesler2	complete blood count	(none)	RBC corpuscular distribution width (RDW) [%] RDW 43423	CC diallel w/par	49	both	7-15wks	N=2	2011

Chesler2:30	Chesler2	colony observation	(none)	time from mate to first litter [d] duration_to_litter 43443	CC diallel w/par	62	both	4wks	N=8	2011

Chesler3:6	Chesler3	metabolic panel	(none)	carbon dioxide (blood CO₂) [mmol/L] carbon_dioxide 43506	CC pre w/par	189	both	7-15wks	N=1	2011

Crabbe4:12	Crabbe4	alcohol quantification	ethanol	blood ethanol concentration [mg/mL] BEC 19112 time after ethanol: 30min 60min 105min 150min	inbred	21	both	7-12wks	N=6	2003

Crowley1:12	Crowley1	open field test	haloperidol	distance traveled, 60 min test [cm] horizontal_act 39412 day: 0 30 60 120	inbred w/CC8	27	m	9-28wks	N=6	2012

Crowley1:33	Crowley1	behavior observation	haloperidol	overt chewing movements, 15 min test [n] overtchew 39433 day: 0 30 60 120	inbred w/CC8	27	m	9-28wks	N=6	2012

CSNA02:4	CSNA02	bottle choice test	(none)	average number of Boost licks over last 3 days of consumption adjusted for body weight [n] boost_licks 62204	inbred	10	both	10-11wks	N=8	2018

CSNA03:31	CSNA03	open field test	(none)	distance traveled in successive 5 min intervals, 60 min test (OFT), CC [cm] amb_dist_OFT_cc 90020 min: 0-5 5-10 10-15 15-20 20-25 25-30 30-35 35-40 40-45 45-50 50-55 55-60	CC w/par	59	both	4-19wks	N=18	2018

CSNA03:128	CSNA03	open field test	(none)	distance traveled in center, 60 min test (OFT), CC [cm] center_dist_OFT_cc 90128	CC w/par	59	both	4-19wks	N=18	2018

CSNA03:266	CSNA03	hole board test	(none)	total number of entries (hole board), CC [n] entries_total_HB_cc 90266	CC w/par	59	both	4-19wks	N=18	2018

CSNA03:272	CSNA03	hole board test	(none)	number of repeat entries (hole board), CC [n] entries_repeat_HB_cc 90272	CC w/par	59	both	4-19wks	N=18	2018

CSNA03:313	CSNA03	open field test	cocaine	distance traveled, last 60 min (post-injection), Day 5 (cocaine) minus Day 3 (cocaine), cocaine sensitization, founders [cm] dist_d5_d3_cocaine_in 90313	inbred w/CC8	10	both	8-14wks	N=6	2018

CSNA03:315	CSNA03	open field test	cocaine	distance traveled, last 60 min (post-injection), Day 5 (cocaine) minus Day 3 (cocaine), cocaine sensitization, DO [cm] dist_d5_d3_cocaine_do 90315	DO population w/par	9	both	8-21wks	N=27	2018

CSNA03:321	CSNA03	open field test	cocaine	distance traveled, last 60 min (post-injection), Day 12 (saline) minus Day 2 (saline), cocaine sensitization, DO [cm] dist_d12_d2_cocaine_do 90321	DO population w/par	9	both	8-21wks	N=27	2018

CSNA03:343	CSNA03	open field test	(none)	distance traveled, first 30 min (pre-injection), on successive days, saline group, CC [cm] dist_f30_cont_cc 90329 day: 1 2 3 5 7 9 11 12 19	CC w/par	58	both	8-21wks	N=4	2018

CSNA03:361	CSNA03	open field test	cocaine	distance traveled, first 30 min (pre-injection), on successive days, cocaine group, founders [cm] dist_f30_cocaine_in 90331 day: 1 2 3 5 7 9 11 12 19	inbred w/CC8	10	both	8-14wks	N=6	2018

CSNA03:370	CSNA03	open field test	cocaine	distance traveled, first 30 min (pre-injection), on successive days, cocaine group, CC [cm] dist_f30_cocaine_cc 90332 day: 1 2 3 5 7 9 11 12 19	CC w/par	58	both	8-21wks	N=4	2018

CSNA03:379	CSNA03	open field test	cocaine	distance traveled, first 30 min (pre-injection), on successive days, cocaine group, DO [cm] dist_f30_cocaine_do 90333 day: 1 2 3 5 7 9 11 12 19	DO population w/par	9	both	8-21wks	N=27	2018

CSNA03:397	CSNA03	open field test	(none)	distance traveled, last 60 min (post-injection), on successive days, saline control, CC [cm] dist_l60_cont_cc 90383 day: 1 2 3 5 7 9 11 12 19	CC w/par	58	both	8-21wks	N=4	2018

CSNA03:692	CSNA03	in vitro assay	(none)	peak-to-trough, indicating level of synchronization in circadian rhythm (max counts/s), in fibroblast cultures, CC [n/s] amplitude_cc 112546	CC w/par	40	both	8-12wks	N=4	2020

Deschepper1:1	Deschepper1	body weight	(none)	body weight [g] bw 10401	inbred	13	both	10wks	N=10	2004

Deschepper1:2	Deschepper1	tail cuff	(none)	systolic blood pressure [mmHg] BP 10402	inbred	13	both	10wks	N=9	2004

Deschepper1:3	Deschepper1	organ weights	(none)	ventricle weight [mg] heart_V 10403 right left both	inbred	13	both	10wks	N=10	2004

Deschepper1:23	Deschepper1	organ weights	(none)	kidney weight [mg] kidney 10423 right left both	inbred	13	both	10wks	N=10	2004

Deschepper1:24	Deschepper1	organ weights	(none)	kidney weight, normalized to body weight [mg] kidney_adj 10424 right left both	inbred	13	both	10wks	N=10	2004

DiPetrillo2:2	DiPetrillo2	urinalysis	(none)	creatinine (urine CREA) [mg/dL] CREA 46102	CC pre w/par	163	m	10wks	N=2	2012

Donahue1:11	Donahue1	DXA	(none)	skull height [mm] skull_height 11520	inbred w/CC7	29	both	15-16wks	N=9	2002

Everett1:5	Everett1	bone dimensions	(none)	mandible, infradentale to posterior ramus [mm] mid_length 11005	inbred	14	both	8-9wks	N=10	2003

Everett1:6	Everett1	bone dimensions	(none)	mandible, posterior molar to menton [mm] mid_height 11006	inbred	14	both	8-9wks	N=10	2003

Everett1:8	Everett1	bone dimensions	(none)	mandible, infradentale to posterior condyle [mm] incisor_condyle 11008	inbred	14	both	8-9wks	N=10	2003

Everett1:9	Everett1	bone dimensions	(none)	mandible, infradentale to gonion [mm] incisor_gonion 11009	inbred	14	both	8-9wks	N=10	2003

Everett1:10	Everett1	bone dimensions	(none)	mandible, posterior molar to posterior condyle [mm] molar_condyle 11010	inbred	14	both	8-9wks	N=10	2003

Everett1:12	Everett1	bone dimensions	(none)	mandible, diastema to pogonion [mm] incisor_region 11012	inbred	14	both	8-9wks	N=10	2003

Everett1:14	Everett1	bone dimensions	(none)	mandible, anterior area [mm²] ant_area 11014	inbred	14	both	8-9wks	N=10	2003

Evsikova1:66	Evsikova1	intake monitoring	(none)	food intake adjusted for body weight [g/kg] food_adj 24766 test start test end	inbred	14	both	26wks	N=6	2009

GMC08:2	GMC08	condenser chamber	(none)	coefficient of variation of transepidermal water loss single measurements [%] TEWL_CV 55702	inbred w/CC8	8	both	11-12wks	N=17	2018

Graubert1:20	Graubert1	histopathology	ENU	gastrointestinal (GI) tumor frequency rate [score] GI_tumor 11620 control ENU	inbred	20	both	13-68wks	N=6	2006

HMDPpheno4:31	HMDPpheno4	fear conditioning test	(none)	fear training activity burst to footshock, shock reactivity, day 1 [cm/s] ftr_post_act_burst 46831	HMDP w/par	94	m	10wks	N=7	2011

HMDPpheno4:41	HMDPpheno4	fear conditioning test	(none)	contextual fear velocity, day 2 [cm/s] ctx_vel 46841	HMDP w/par	94	m	10wks	N=7	2011

HMDPpheno4:71	HMDPpheno4	fear conditioning test	(none)	cued fear, percent time immobile, day 3 [%] imob 46871 pre-cue cue	HMDP w/par	94	m	10wks	N=7	2011

Jax5:2	Jax5	colony observation	(none)	latency to first litter per dam, dam age at first litter minus age at mating [wks] latency_first_litter 31402	inbred	35	f	6-40wks	N=46	2009

Jax5:83	Jax5	colony observation	(none)	age at first litter [wks] age_first_litter 31483	inbred	35	f	varies	N=46	2009

Jax5:84	Jax5	colony observation	(none)	age of dam at birth of litter [wks] dam_age_at_litter 31484	inbred	35	f	varies	N=184	2009

Johnson1:6	Johnson1	colony observation	(none)	age of older group (local parameter) [d] age_old 1406	inbred	27	both		N=12	2000

Justice2:13	Justice2	complete blood count	(none)	RBC corpuscular distribution width (RDW) [%] RDW 13213	inbred	16	both	12-16wks	N=12	2002

Koide1:1	Koide1	home cage monitoring	(none)	number of beam breaks, light 12h period [n] LA_LIGHT 1801	wild-derived Mishima	11	f	8-13wks	N=10	2000

Kumar4:26	Kumar4	gait analysis	(none)	lateral distance separating hind paws (keypoints), mean [cm] step_width_mean 114456	inbred w/CC8	62	both	10-20wks	N=19	2021

Kumar4:27	Kumar4	gait analysis	(none)	lateral distance separating hind paws (keypoints), median [cm] step_width_median 114457	inbred w/CC8	62	both	10-20wks	N=19	2021

Loos2:22	Loos2	home cage monitoring	(none)	change in activity proportion: anticipation of phase change, over 3 days of testing activity_anticipation 54022 dark light	inbred w/CC7	11	m	8-12wks	N=40	2016

Loos2:57	Loos2	home cage monitoring	(none)	long arrest, duration [s] long_arrest_dur_LT 54057	inbred w/CC7	11	m	8-12wks	N=40	2016

Loos2:73	Loos2	home cage monitoring	(none)	cumulative duration of long shelter visits (sheltering), over 3 days of testing [s] long_shelter_dur 54073 dark light	inbred w/CC7	11	m	8-12wks	N=40	2016

Mathes1:7	Mathes1	intake monitoring	exercise	caloric intake [kcal/d] calories 45207 before exercise during exercise	CC pre w/par	183	m	10-12wks	N=1	2011

Odet2:8	Odet2	microscopy	(none)	percentage of sperm that are motile [%] sperm_motile 53808 min: 10 30 60 90 120	inbred w/CC8	8	m	10-66wks	N=13	2015

Paigen1:5	Paigen1	body weight	high-fat diet	body weight [g] bw 2905 start after 8wks on diet fold change	inbred	43	both	7-11wks	N=12	2000

Paigen1:16	Paigen1	histopathology	high-fat diet	gallbladder, number of sandy stones [n] sandysto 2916	inbred	43	both	15-19wks	N=8	2000

Paigen1:20	Paigen1	lipid profile	high-fat diet	total cholesterol (plasma) [mg/dL] totalCh 2920	inbred	43	both	15-19wks	N=9	2000

Paigen1:22	Paigen1	lipid profile	high-fat diet	plasma cholesterol not in the HDL fraction [mg/dL] nonHDL_Ch 2922	inbred	43	both	15-19wks	N=8	2000

Paigen1:23	Paigen1	lipid profile	high-fat diet	percentage of total plasma cholesterol in HDL fraction [%] pctHDL_TCH 2923	inbred	43	both	15-19wks	N=8	2000

Paigen2:5	Paigen2	lipid profile	high-fat diet	non-HDL cholesterol (plasma) [mg/dL] nonHDL 9905 baseline after 17wks on diet Δchange	inbred w/CC7	42	both	7-9wks	N=9	2002

Paigen2:21	Paigen2	lipid profile	high-fat diet	triglycerides (plasma, 4h fast) [mg/dL] TG 9921 baseline after 17wks on diet Δchange	inbred w/CC7	42	both	7-9wks	N=9	2002

Paigen4:4	Paigen4	lipid profile	(none)	triglycerides (plasma, 4h fast) [mg/dL] TG 19704	inbred w/CC7	43	both	10wks	N=12	2002

Peters1:9	Peters1	complete blood count	(none)	RBC corpuscular distribution width (RDW) [%] RDW 6209	inbred w/CC7	43	both	10wks	N=12	2001

Peters4:5	Peters4	complete blood count	(none)	red blood cell count (RBC; per volume x 10⁶) [n/µL] RBC 24305 6mo 12mo 18mo 24mo	inbred	30	both		N=7	2007

Peters4:65	Peters4	complete blood count	(none)	mean RBC corpuscular hemoglobin content (MCH) [pg] MCH 24365 6mo 12mo 18mo 24mo	inbred	30	both		N=7	2007

Powell1:1	Powell1	in vitro assay	Neisseria musculi	oral cavity bacterial colony count (CFU/swab) post inoculation (x 10³) [n] bacterial_load 62801 wk 1 wk 2 wk 3 wk 4 wk 5 wk 6 wk 7 wk 8 wk 9 wk 10 wk 11 wk 12	inbred	8	both	8-16wks	N=12	2018

Reed1:3	Reed1	body size and weight	(none)	body weight [g] bw 32603	inbred	28	m	29-67wks	N=12	2009

Reed1:4	Reed1	body size and weight	(none)	body length (from base of lower incisors to base of anus) [cm] length 32604	inbred	28	m	29-67wks	N=12	2009

Rhodes1:1	Rhodes1	running wheel monitoring	exercise	locomotor activity [km/d] activity 34601 control with running wheel	inbred	12	both	8-15wks	N=4	2010

Rhodes1:9	Rhodes1	body weight	exercise	final body weight [g] BW_end 34609 control with running wheel	inbred	12	both	15wks	N=4	2010

Rhodes1:11	Rhodes1	body weight	exercise	change in body weight [ratio] BW_chg 34611 control with running wheel	inbred	12	both	15wks	N=4	2010

Rusyn2:17	Rusyn2	metabolic panel	trichloroethylene	alanine transaminase (serum ALT), treated group [IU/L] ALT_tce 36117 time: 2h 8h 24h	inbred	17	m	7wks	N=3	2010

Rusyn6:30	Rusyn6	RNA expression profiling	trichloroethylene	Ppara, mRNA in liver, relative to control group [ratio] Ppara_liver_tce 51230	inbred	7	m	6-7wks	N=3	2014

Seburn1:5	Seburn1	body weight	(none)	body weight [g] bw 9205 start end percent change	inbred	16	both	7-9wks	N=8	2001

Seburn1:8	Seburn1	monitoring system	(none)	oxygen volume, 3 day test [mL/kg/h] VO2 9208 daily light dark	inbred	16	both	7-9wks	N=8	2001

Seburn1:17	Seburn1	monitoring system	(none)	body heat production, 3 day test [kcal/h] heat 9217 daily light dark	inbred	16	both	7-9wks	N=8	2001

Seburn1:26	Seburn1	monitoring system	(none)	ambulatory activity, beam breaks per min, 3 day test [n/min] aa 9226 daily light dark	inbred	16	both	7-9wks	N=8	2001

Seburn1:29	Seburn1	monitoring system	(none)	rearing activity, beam breaks per min, 3 day test [n/min] ra 9229 daily light dark	inbred	16	both	7-9wks	N=8	2001

Seburn1:37	Seburn1	intake monitoring	(none)	water intake [mL] water 9237 3 day total daily daily adj for body weight	inbred	16	both	7-9wks	N=7	2001

Seburn2:1	Seburn2	grip strength	(none)	grip strength, peak tension over 3 trials [g] grip_strength 24801 6mo 12mo 18mo 24mo	inbred	32	both		N=8	2008

Thomsen1:7	Thomsen1	open field test	cocaine	total activity, test 2, 3h test [n] activ_cocaine2 40707 baseline dose mg/kg i.p.: 3 10 32	inbred	15	both	8-10wks	N=8	2011

Thomsen2:6	Thomsen2	open field test	quinelorane	total activity, dose response to D2 agonist, 3h test [n] activ_D2 40806 baseline dose mg/kg i.p. 0.03 0.32 3.2 5.6	inbred	15	both	8-10wks	N=8	2011

Threadgill1:20	Threadgill1	metabolite quantification	acetaminophen	ratio of reduced (GSH) to oxidized (GSSG) glutathione [ratio] GSHratio 19420 control post-Rx 300mg/kg	inbred w/CC7	36	m	8-17wks	N=2	2005

Tordoff1:2	Tordoff1	body weight	(none)	average body weight during NaCl test (local parameter) [g] NaCl_bwavg 6102	inbred	28	m	4-12wks	N=12	2001

Tordoff1:8	Tordoff1	body weight	(none)	average body weight during KCl test (local parameter) [g] KCl_bwavg 6108	inbred	28	m	4-12wks	N=12	2001

Tordoff1:15	Tordoff1	body weight	(none)	average body weight during CaCl2 test (local parameter) [g] CaCl2_bwavg 6115	inbred	28	m	4-12wks	N=12	2001

Tordoff1:21	Tordoff1	body weight	(none)	average body weight during NH4Cl test (local parameter) [g] NH4Cl_bwavg 6121	inbred	28	m	4-12wks	N=12	2001

Tordoff1:22	Tordoff1	bottle choice test	(none)	preference for NH4Cl (ammonium chloride) solutions [%] NH4Cl_pref 6122 concentration (mM): 10 30 100 300	inbred	28	m	4-12wks	N=11	2001

Tordoff2:8	Tordoff2	body weight	(none)	body weight average [g] bwavg 6308	inbred	28	m	4-12wks	N=12	2001

Tordoff2:13	Tordoff2	intake monitoring	(none)	food intake [g] fi 6313 daily daily adj for body weight	inbred	28	m	4-12wks	N=12	2001

Tordoff2:27	Tordoff2	intake monitoring	(none)	water intake [mL] wi 6327 daily daily adj for body weight	inbred	28	m	4-12wks	N=12	2001

Vinyard1:3	Vinyard1	bone dimensions	(none)	distance from the incisor alveolus to the caudal surface of the mandibular condyle (jaw length) [mm] jaw_length 30403	inbred	21	both	9-12wks	N=10	2009

Vinyard1:8	Vinyard1	body weight	(none)	body weight [g] bw 30408	inbred	21	both	9-12wks	N=10	2009

Vulpe1:1	Vulpe1	mineral quantification	(none)	copper (Cu) content in liver, dry weight [µg/g] copper 36801	inbred	18	both	8wks	N=6	2010

Wahlsten1:4	Wahlsten1	organ weights	(none)	brain weight, after fixation and trimming [g] brain_wt 10804 weight as percent of body weight	inbred	21	both	12wks	N=10	2003

Wahlsten2:11	Wahlsten2	behavior observation	(none)	wildness rating, mean during weighing [score] weigh 16011	inbred	21	both	10-12wks	N=9	2003

Willott1:7	Willott1	acoustic startle test	(none)	habituation: ratio of final 4 trials to initial 4 trials (<1.0=diminished ASR) [ratio] ASR_habituation 9107	inbred w/CC7	40	both	5-6wks	N=10	2002

Yuan3:1	Yuan3	metabolic panel	(none)	alanine transaminase (plasma ALT) [IU/L] ALT 24401 6mo 12mo 18mo	inbred	32	both		N=6	2008

Yuan3:6	Yuan3	metabolic panel	(none)	lipase (plasma LIP) [U/L] LIP 24406 6mo 12mo 18mo	inbred	32	both		N=7	2008

Yuan3:31	Yuan3	metabolic panel	(none)	magnesium (serum Mg) [mg/dL] Mg 24431 6mo 12mo 18mo	inbred	32	both		N=6	2008

Yuan3:51	Yuan3	metabolic panel	(none)	albumin (plasma Alb) [g/dL] ALB 24451 6mo 12mo 18mo	inbred	32	both		N=6	2008

Yuan3:56	Yuan3	metabolic panel	(none)	total protein (plasma TP) [g/dL] TP 24456 6mo 12mo 18mo	inbred	32	both		N=7	2008

Yuan3:66	Yuan3	metabolic panel	(none)	bilirubin (serum TBIL) [µmol/L] TBIL 24466 6mo 12mo 18mo	inbred	32	both		N=7	2008

List measures where CAST/EiJ is an outlier

Filter Table Results